{"id":"W2892202359","doi":"10.1200/jco.2018.36.15_suppl.5576","title":"Progression free survival (PFS) as a surrogate endpoint for overall survival (OS) in first-line advanced ovarian cancer (AOC) therapy: A Gynecologic Cancer InterGroup individual (GCIG) patient-level (IPD) analysis of multiple randomized trials.","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Cancer Care Ontario; BC Cancer Agency","funders":"","keywords":"Medicine; Surrogate endpoint; Clinical endpoint; Progression-free survival; Internal medicine; Randomized controlled trial; Oncology; Clinical trial; Overall survival","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.04458265,0.001992987,0.008786913,0.002485261,0.0003648731,0.002396458,0.001031242,0.001797843,0.00166209],"category_scores_gemma":[0.04966428,0.0007824121,0.03076238,0.00234878,0.0007345084,0.001265775,0.001239094,0.002008276,0.0001560036],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001342997,"about_ca_system_score_gemma":0.001066286,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008318948,"about_ca_topic_score_gemma":0.001678969,"domain_scores_codex":[0.9584683,0.03433476,0.003389932,0.002155249,0.001282568,0.0003692884],"domain_scores_gemma":[0.9591859,0.03195263,0.00506803,0.002654436,0.0007502334,0.0003887942],"domain_codex":null,"domain_gemma":"methods","domain_candidate":"methods","domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.03612889,0.0001098475,0.01790459,0.01304693,0.9184216,0.0000933575,0.00005652303,0.001500596,0.0006938187,0.0002057226,0.0002814304,0.01155681],"study_design_scores_gemma":[0.01268575,0.004349974,0.01597076,0.001010392,0.9610735,0.0001358649,0.00003917785,0.002196493,0.0004939796,0.0008068119,0.001198579,0.00003866687],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.3475763,0.6263505,0.01782468,0.001405169,0.0008217998,0.002191524,0.002283894,0.0001987405,0.001347358],"genre_scores_gemma":[0.969206,0.01976783,0.00741159,0.0007261166,0.0002732187,0.001333192,0.0009116302,0.00004296873,0.0003272736],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.9554173,"threshold_uncertainty_score":0.2357784,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2564612880490028,"score_gpt":0.5040262150334156,"score_spread":0.2475649269844128,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}